We provide you with 20 years of free, institutional-grade data for STRO stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of STRO. Explore the full financial landscape of STRO stock.
| Reported Date | CIK | Ticker | Type |
|---|
Sutro Biopharma, Inc(NASDAQ:STRO) 
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF. The company's prod...
The information provided in this report about STRO stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.